Finnrick
← Semaglutide vendors

NexaphSemaglutide

15 testslatest 6 Mar 2026$1.90/mg median
Visit websitenexaph.comIntelligence report31 pages · who runs this vendorMonitor this vendor24/7 safety alerts · Finnrick Gold

Free peptide testing

Ordered Semaglutide from Nexaph? Mail in a sample (US only) and let us test it for free.

Test my supply
+3 more ↓
31%
Finnrick rating
#1 of 57 Semaglutide vendors
2 of 15 classifiable tests passed
natural 13% · customers 4.3★ (2)
methodology · Purity focus
Finnrick analysis · Semaglutide

Nexaph's Semaglutide profile is driven by repeated purity misses under the 99.5% cutoff, including 95.5–95.6% results and a later 99.2% result. Identity passed throughout, but fill often ran high up to +27%.

methodology →
vendor intelligence report
Vendor Intelligence Report: Nexaph

Corporate records, RDAP data and site emails trace Nexaph through a fragmented operator identity rather than a clean public counterparty. The report maps sister-brand infrastructure, COA-cloning pathways and a certification/payment layer that changes buyer recourse.

31 pages8 risk factors assessed3 Jul 2026
read the report
Peptides
11 rated · tap to focus
#
Peptide
$/MG
Rating
N
1
GHK-Cu
$0.25
91%
11
2
Tirzepatide
$0.81
77%
56
3
Retatrutide
$2.46
73%
100
4
Ipamorelin
$1.30
60%
10
5
BPC-157
$1.10
58%
17
6
Cagrilintide
$3.50
55%
12
7
TB-500
$1.61
37%
6
8
Tesamorelin
$2.81
35%
28
9
Semaglutideselected
$1.90
31%
15
10
MOTS-c
$1.88
25%
4
11
CJC-1295
$2.40
24%
7
Contact channels
2 channels on file
Websitenexaph.comEmailcain@nexaph.com
Rating trend
Semaglutide from this vendor, after each test
CUMULATIVE FINNRICK RATING
83%+65%+48%+30%+<30%11 Jun 2025: 65%11 Jun 2025: 59%14 Jul 2025: 51%14 Jul 2025: 46%14 Jul 2025: 41%14 Jul 2025: 36%16 Jul 2025: 40%16 Jul 2025: 36%16 Jul 2025: 32%16 Jul 2025: 36%22 Jul 2025: 33%22 Jul 2025: 30%22 Jul 2025: 28%22 Jul 2025: 26%6 Mar 2026: 28%9 Aug 2026: current 31%65%28%31%Jun 25Aug 26
Showing Semaglutide tests only

Free peptide testing

Ordered Semaglutide from Nexaph? Mail in a sample (US only) and let us test it for free.

Test my supply
Nexaph Semaglutide test history
15 tests · 2 pass · 13 fail
COA-backed lab tests
DateResultTestLabPurityDosageLabelCOA
6 Mar 2026Fail
7tzruhm
Tested
lab nameView COA
22 Jul 2025Fail
v9aqjzl
Tested
lab nameView COA
22 Jul 2025Fail
prr8krp
Tested
lab nameView COA
22 Jul 2025Fail
ox47sjm
Tested
lab nameView COA
22 Jul 2025Fail
l5cuonx
Tested
lab nameView COA
16 Jul 2025Pass
jyl3mhm
Tested
lab nameView COA
16 Jul 2025Fail
iv46drt
Tested
lab nameView COA
16 Jul 2025Fail
9xu9kb6
Tested
lab nameView COA
16 Jul 2025Pass
2x9noic
Tested
lab nameView COA
14 Jul 2025Fail
yv6347c
Tested
lab nameView COA
1-10 of 15

About Nexaph test results from Finnrick

Nexaph is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 11 peptides and 266 tests, including ratings, observed price signals, recent test dates, and correction history where available.

Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.

The most visible Nexaph peptides in this dataset are Semaglutide (15 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.

Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 200 recent tests.

Corrections
0 corrections
No corrections.

Free peptide testing

Ordered Semaglutide from Nexaph? Mail in a sample (US only) and let us test it for free.

Test my supply